Literature DB >> 13920952

Persistence of starch derivatives and dextran when infused after hemorrhage.

W L THOMPSON, J J BRITTON, R P WALTON.   

Abstract

Entities:  

Keywords:  DEXTRAN/metabolism; HEMORRHAGE/experimental; STARCH/metabolism

Mesh：

Substances：

Year:  1962        PMID： 13920952

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN： 0022-3565            Impact factor:   4.030


× No keyword cloud information.
  11 in total

1.  Comparative study on the influences of plasma substitutes on the blood coagulation.

Authors:  Y Matsuura; T Tsubokura; M Tamura
Journal:  Jpn J Surg       Date:  1973-06

2.  Comparison of hydroxyethyl starch with plasma and dextrans in severe haemodilution.

Authors:  M Takaori; P Safar; S J Galla
Journal:  Can Anaesth Soc J       Date:  1968-07

3.  [Second increase in plasma volume after single infusion of hydroxyethyl starch (author's transl)].

Authors:  H Köhler; W Kirch; H Pitz
Journal:  Klin Wochenschr       Date:  1978-10-01

4.  [The elimination of hydroxyethyl starch 200/0.5, dextran 40 and oxypolygelatine (author's transl)].

Authors:  H Köhler; H Zschiedrich; A Linfante; F Appel; H Pitz; R Clasen
Journal:  Klin Wochenschr       Date:  1982-03

5.  Effect of hydroxyethyl starch on plasma volume and hematocrit following hemorrhagic shock in dogs: comparison with dextran, plasma and Ringer's.

Authors:  G C Vineyard; B E Bradley; A Defalco; D Lawson; T A Wagner; W K Pastis; F A Nardella; J R Hayes
Journal:  Ann Surg       Date:  1966-11       Impact factor: 12.969

6.  Mechanisms of postoperative prolonged plasma volume expansion with low molecular weight hydroxethy starch (HES 200/0.62, 6%).

Authors:  A C Degrémont; M Ismaïl; M Arthaud; B Oulare; O Mundler; M Paris; J F Baron
Journal:  Intensive Care Med       Date:  1995-07       Impact factor: 17.440

Review 7.  Use of plasma volume expanders in myocardial revascularisation.

Authors:  J H Lacy; C B Wright
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

8.  Post-transfusion survival of hydroxyethyl starch 450/0.70 in man: a long-term study.

Authors:  J M Mishler; C R Ricketts; E J Parkhouse
Journal:  J Clin Pathol       Date:  1980-02       Impact factor: 3.411

9.  Changes in the molecular composition of circulating hydroxyethyl starch following consecutive daily infusions in man.

Authors:  J M Mishler; C R Ricketts; E J Parkhouse
Journal:  Br J Clin Pharmacol       Date:  1979-05       Impact factor: 4.335

10.  A clinical study of low molecular weight-hydroxyethyl starch, a new plasma expander.

Authors:  J M Mishler; E S Parry; B A Sutherland; J R Bushrod
Journal:  Br J Clin Pharmacol       Date:  1979-06       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.